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Abstract: The ability to glycosylate surfaces has medical and diagnostic applications, but there is
no technology currently recognized as being able to coat any surface without the need for prior
chemical modification of the surface. Recently, a family of constructs called function-spacer-lipids
(FSL) has been used to glycosylate cells. Because it is known that lipid-based material can adsorb onto
surfaces, we explored the potential and performance of cell-labelling FSL constructs to “glycosylate”
non-biological surfaces. Using blood group A antigen as an indicator, the performance of a several
variations of FSL constructs to modify a large variety of non-biological surfaces was evaluated.
It was found the FSL constructs when optimised could in a few seconds glycosylate almost any
non-biological surface including metals, glass, plastics, rubbers and other polymers. Although
the FSL glycan coating was non-covalent, and therefore temporary, it was sufficiently robust with
appropriate selection of spacer and surface that it could capture anti-glycan antibodies, immobilize
cells (via antibody), and withstand incubation in serum and extensive buffer washing, making it
suitable for diagnostic and research applications.
Keywords: function-spacer-lipid; blood group A; nanofibres; surface-coating; glyco-coating;
glyco-landscape; shear stress
1. Introduction
Glycosylation of biological surfaces is well established and known to have important roles and
the mimicking of these glycosylation patterns on non-biological surfaces has uses and potential in
basic research as well as techniques ranging from medical applications [1] through to diagnostics [2].
Chemical glycosylation of surfaces usually involves covalent immobilisation of glycans onto membrane
surfaces utilising a variety of coupling reactions [3]. Even enzymatic glycosylation requires chemical
coating with a glyco-primer [3]. However, a few researchers have used physical adsorption of
lipid-linked oligosaccharides onto membranes, as originally used by Feizi and co-workers [3]. We
report here an extension of this physical adsorption method to rapidly coat almost any non-biological
surface by using function-spacer-lipid (FSL) constructs previously used for the modification of cells
and viruses [4–7].
FSL constructs unlike other lipidated glycans and neoglycolipids have a spacer included in their
architecture. This spacer facilitates conjugation of the glycan to the lipid tail and can also be designed to
bring additional features to the construct, including controlled spacing away from a membrane, ligand
spacing and enhanced attachment and retention on biological and non-biological surfaces [4,5]. Unlike
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in the plasma membrane of a cell where the lipid tail of the FSL construct is able to insert into the
lipid bilayer, on solid non-biological surfaces it instead imparts on the FSL construct an amphiphatic
character, which drives the self-assembling process on surfaces and probably their surface adhesion
via water-exclusion [4].
There are a large range of glyco-FSL constructs and many have been shown to have biological
applications [4,5]. For this study, two primary FSL construct variants (Figure 1) were chosen,
one based on the short 2 nm adipate spacer (Atri-Ad-DOPE) and the other on the longer 7
nm carboxymethylglycine spacer (Atetra-CMG-DOPE). Techniques for the visualization of these
specific constructs are well-established [4,5,8]. Using these two constructs, each with potentially
very different attributes, we examined the performance of FSL constructs to modify a range of
non-biological materials.
Figure 1. Schematic diagrams of the two primary blood group A function-spacer-lipid (FSL) constructs
used in this paper. The upper schematic Atri-Ad-DOPE shows an FSL with a trisaccharide generic
blood group A antigen and a short 2 nm adipate spacer while the lower schematic Atetra-CMG-DOPE
shows a type 2 chain specific A tetrasaccharide FSL with a longer 7 nm carboxymethylglycine spacer.
Both constructs have the same dioleoylphosphatidylethanolamine (DOPE) lipid tail.
2. Results and Discussion
2.1. Surface Variations
2.1.1. Surface Variations—Coupons
A variety of standardized materials in the form of coupons were labelled with both Atri-Ad-DOPE
and Atetra-CMG-DOPE (Table 1 and Figure 2). With the exception of those surfaces that degraded
(corroded) under experimental conditions (e.g., iron, copper), all surfaces were labelled with both FSL
constructs. The relative surface areas of the coupons and their ability to retain the enzyme immunoassay
(EIA) precipitate potentially contributed to the variations in intensity seen between different materials.
Additionally, it is possible that on some surfaces the development of the chromogenic precipitate may
have also been inhibited to some degree by (electro) chemical activity of the surface.
When comparing the results between the two different FSL constructs on the same surface there
were often differences in their ability to remain as the discrete spot originally applied. In general,
on metallic surfaces, the Atri-Ad-DOPE construct often smeared across the coupon. This smearing
probably occurred during the first EIA washing step. The most extreme smearing occurred with
Atri-Ad-DOPE on hydroxyapatite where this FSL construct spread almost over the entire coupon, while
the Atetra-CMG-DOPE on the same coupon remained as a discrete spot. In general plastics, rubbers
and other polymers are labelled similarly with both constructs, although there were differences between
materials. For example, both FSL constructs smeared on PEEK, CPVC, polycarbonate and PTFE, while
Atetra-CMG-DOPE appeared to smear more on polystyrene and PVC than did Atri-Ad-DOPE. These
surface differences would be expected due to the different surface characteristics including charge and
hydrophobicity and relative abilities to interact with different zones of the FSL constructs. Despite the
differences in surface composition both FSL construct variations were able to adhere to all surfaces
tested (Table 1).
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Table 1. Summary of surfaces successfully coated with Atri-Ad-DOPE and Atetra-CMG-DOPE
constructs (with examples shown in Figures 2 and 4).
Surface Alphabetical Listing of Materials Modified by Blood Group AFsl Constructs
Metals Aluminum, Copper, Gold, Nickel, silver, Stainless Steel (304),Stainless Steel (316L), Stainless Steel (347), Titanium
Plastics/
Polymers/
Rubbers/
Fibres (Alphabetical Order)
Acrylonitrile butadiene styrene (ABS), Cellulose acetate
(transparency film), Cellulose acetate (nanofibres), Chlorinated
polyvinyl chloride (CPVC), Chlorosulfonated polyethylene (CSPE,
hypalon), Cotton, Ethylene propylene diene monomer (EPDM)
rubber, Mixed cellulose esters, Natural rubber, Nitrile butadiene
(NBR) rubber, Nitrocellulose, Poly(methyl methacrylate) (PMMA:
Plexiglass), Polyamide (Nylon), Polyamide PA66 nanofibres,
Polycarbonate, Polyetheretherketone (PEEK: Arlon 1330),
Polyethylene terephthalate (PET: Polyester, Dacron), Polyethylene
terephthalate glycol (PETG), Polyethylene UMHW, Polypropylene,
Polystyrene, Polytetrafluoroethylene (PTFE), Polyurethane (high
temperature polymer), Polyvinyl butyral nanofibres (PVB),
Polyvinyl chloride (PVC), Polyvinylidene fluoride (PVDF),
Regenerated cellulose, Silicone rubber, Silk, Silica gel S60 (TLC
plate), Silica gel C18 (TLC plate), Viton rubber, wood (various)
Other Borosilicate glass, Concrete, Ceramic tile-glazed, Hydroxyapatite,Ceramic porcelain, Paper-24 varieties of coated and uncoated papers
Figure 2. Photographic images of 20 representative coupons (see also Table 1) each spotted with 1 µL
of Atri-Ad-DOPE (12 o’clock spot) and Atetra-CMG-DOPE (6 o’clock spot). Schematic diagram shows
experimental layout. FSL spotted coupons were allowed to air dry then visualised by EIA using
monoclonal anti-A and precipitating chromogenic substrate (purple).
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2.1.2. Surface Variations—Printing and Direct Application
In addition to disc coupons, a variety of other surfaces were also available (Table 1). Those
available in planar form were able to have their blood group A FSL coating applied with an inkjet
printer (Figure 3 [8]). Inkjet printing of the FSL constructs was particularly valuable as it also provided
discrete and identifiable borders of where the FSL had been applied, thus allowing for observations
of the degree of smearing, or “bleed”. Furthermore, because the FSL could be printed as identifying
information it was able to facilitate sample identification (Figure 3). Planar surfaces could also be
constructed into microplates (Figure 3 [8]).
Figure 3. An example of microplate prepared with blood group A and B FSL constructs printed on
paper (MG paper—cellulose esters) and prepared as a microplate to determine specificity of monoclonal
reagents. Reprint from [8]. Copyright 2014 with permission from John Wiley and Sons. Alphanumeric
characters appear when developed in the EIA reaction wherever the monoclonal reagent has bound
to the FSL. Area outside of the printed area is the “internal” negative control and/or blank. In this
example antibodies in co-ordinates A1, A4, B3 have anti-A specificity, those in A2, B1 and B4 have
anti-B specificity while those in A3 and B2 anti-A + B specificity. This EIA technique either with printed
alphanumeric characters or spots of FSL constructs on a variety of different surfaces and optionally
prepared as microplates was the basis for most experiments.
A variety of planar surfaces were printed with Atri-Ad-DOPE and stained by EIA (Figure 4).
Non-inkjet printable surfaces such as microspheres, glass fibres threads and gold foil were labelled
by application of the FSL to their surface by either immersion or application with a paintbrush. No
surface was found that was unable to be FSL modified, and although some surfaces appeared to stain
stronger than others, this was probably due to differences in surface area, organization of adhered
FSLs, and ability of the EIA precipitate to remain at the surface.
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Figure 4. Examples of 21 different surfaces reacted with Atri-Ad-DOPE. FSL constructs on most
surfaces were inkjet printed as words identifying each surface material. The microspheres and glass
fibre were coated with FSL construct by immersion, while a paintbrush was used to apply the FSL
construct to gold foil. The blood group A FSL constructs bound to the various surfaces were visualised
by EIA using monoclonal anti-A and a precipitating chromogenic substrate.
2.1.3. Cell Adhesion to Printed FSL Constructs
The binding of red cells can also be used to detect the presence of constructs. In this scenario
rather than using an alkaline phosphatase labelled anti-immunoglobulin to detect the primary IgM
antibodies (Ab) bound to the blood group A constructs as would be done in the EIA, the IgM anti-A
bound to blood group A FSL is used to capture blood group A red cells. As seen in Figure 5 a
variety of blood group A, B and related FSL antigens were printed onto different surfaces with an
inkjet printer. Immunostaining of these FSLs with an antibody mix (anti-A + anti-B) that reacts
with all constructs reveals their presence (although the silver filter membrane appears to be poorly
reactive). When these surfaces, after reacting with IgM anti-A, are overlaid with blood group A red
cells (instead of a secondary anti-Ig enzyme conjugate as in the EIA), the red cells bind very strongly
and specifically to blood group A FSL/Ab complex areas on the surface. Subsequent experiments (not
shown) demonstrate that the enzyme precipitate produced in the EIA reaction is retained very poorly
on some surfaces like silver, despite significant FSL binding (as visualised by cell capture). Not only
does this experiment show an alternative method to visualise constructs on some surfaces (particularly
metals) but also that the binding of the FSL to a surface is sufficient to immobilise cells under low
shear forces. If these surfaces with captured cells are subjected to higher shear forces (e.g., washing or
agitation) then the red cells will be dislodged from the surface.
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Figure 5. Capture of red blood cells onto printed glyco-FSLs. Six different ABO related FSL constructs
based on adipate and CMG spacers were printed onto five different surfaces. The upper row of images
show the presence of these FSL constructs on surfaces using EIA and monoclonal antibodies directed
against both the A and B antigens. The middle row of images show blood type specific binding of
these same surfaces when reacted with monoclonal IgM anti-A and used to capture blood group A red
cells. Of particular note is the poor EIA and strong red cell binding reaction of the silver membrane,
highlighting the inability of some surfaces to show strong reactivity by the EIA method. The lower
row of images are SEM 2000ˆ magnifications of the edge of the printed areas, showing delineation
between the printed blood group A FSL + IgM anti-A capture of blood group A red cells area and
unprinted areas. It can be seen by its ability to immobilise RBCs that the monoclonal anti-A used
had higher cross reactive affinity for the Forssman disaccharide (2FSad) than for the pentasaccharide
(5FSad). This is expected as the Forssman antigen is a cross-reactive target of the anti-A reagent used,
and the pentasccahride with a more complete Forssman structure will have less off-target binding [9].
2.1.4. Microsphere Binding
If the FSL constructs are applied to microspheres (by simple contact), and these FSL modified
microspheres are then coated with IgM antibody (and washed), these microspheres are able to
specifically capture antigen positive cells (Figure 6). The SEM image (Figure 6, inset c) appears to show
the bound red cells distorting and having firm contact with the modified microsphere surface. However
the interaction is not robust, and captured red cells can be released from the microspheres by subjecting
them to shear forces such as agitation (e.g., vortex) or aggressive washing procedures. A range of
different microspheres including paramagnetic beads [10] have been modified with FSL constructs.
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Figure 6. Attachment of blood group A red cells onto 20 µm polycarbonate microspheres coated with
Atri-Ad-DOPE and IgM anti-A. Inset (a) shows light microscopy image at 1000ˆmagnification while
insets (b) & (c) show higher magnifications under SEM (post glutaraldehyde fixation). Although the
main image and inset (a) appears to show cells only on the perimeter of the microsphere, this is an
artefact due to the microscopic plane of focus. Varying the plane of focus reveals red cells evenly
distributed over the microspheres. No binding occurred on controls.
2.1.5. Nanofibre Incorporation
The ability of the FSL constructs to self-assemble on nanofibres during the electrospinning process
was established by adding the Atri-Ad-DOPE construct to two different nanofiber polymers (CA and
PVB) before electrospinning of the fibres [11]. The resulting fibres when stained with the EIA technique
shows incorporation of the FSLs into the fibres, and presence of the immunoreactive antigen at the
nanofibre surface (Figure 7). No disruption in the formation or structure of the nanofibres was observed
when the FSL constructs were included in the polymers.
Figure 7. Incorporation of Atri-Ad-DOPE into nanofibres during the electrospinning process. Cellulose
acetate (CA) and polyvinyl butyral (PVB) nanofibres were electrospun with Atri-Ad-DOPE and
Btri-Ad-DOPE constructs included in the pre-spinning liquid polymers. Spun nanofibres were twisted
into cords and then immunostained. Staining with monoclonal anti-A by the EIA method was able
to demonstrate incorporation of the blood group A FSL construct into both nanofibres during the
electrospinning process.
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2.2. Binding Characteristics and Performance
2.2.1. Molarity
In order to determine the molar range in which Atri-Ad-DOPE and Atetra-CMG-DOPE would
produce detectable EIA reactions a series of dilutions (in PBS pH 7) of the FSLs was prepared over the
range of 5–1000 µmol/L and contacted with paper for 5 min, washed and allowed to dry. As can be
seen in Figure 8 the 1 µL spots of both constructs were easily detectable at 5 µmol/L. Of note was that
with concentrations greater than 50 µmol/L smearing of the original spot occurred. This is probably
due to layering of the FSL constructs upon themselves, and with these multilayers being dissociated
during the washing process. As the time of contact for an FSL to adhere to a surface can be extremely
rapid (see below) the loosely bound FSL’s released during the washing process probably immediately
bound to unmodified surface and remained adhered. It is also of note that the Atri-Ad-DOPE construct
appeared to bleed more than the Atetra-CMG-DOPE construct, an observation concordant with those
seen before (Figure 2). This suggests that potentially the CMG based FSL constructs are able to interact
more strongly with each other than the adipate based constructs.
Figure 8. Effect of molar concentration on the surface binding characteristics of Atri-Ad-DOPE and
Atetra-CMG-DOPE when applied as a 1 µL spots on MG paper.
2.2.2. pH
The effect of pH was studied by preparing 50 µmol/L Atri-Ad-DOPE and Atetra-CMG-DOPE
in a series of 0.1 M phosphate buffers over the range of pH 5–9. These pH adjusted FSL constructs
were applied to MG paper and allowed to be in contact with the surface for between 1 and 1800 s
minutes (30 min) before being washed in PBS pH 7. Binding of the FSL constructs to the surface was
then determined by EIA (Figure 9).
It can be seen that although binding of both constructs were largely unaffected by acidic pH the
Atetra-CMG-DOPE required more time (30–60 s) to get good binding to the paper surface, compared
with 1 s for Atri-Ad-DOPE. The binding of Atri-Ad-DOPE constructs appeared to be indifferent to pH
over the range of 5–9 while the Atetra-CMG-DOPE construct appeared to have improved binding at
higher pH (e.g., 30 s at pH 5 compared with 6 s at pH 9). These results possibly relate only to MG paper
and performance on other surfaces (and with different concentrations of FSL constructs and ionic
strength) could potentially produce different results to those obtained on paper. See also results below
relating to surface differences observed at the same pH or with different application buffer/solvent.
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Figure 9. Effect of application buffer pH on surface binding characteristics of Atri-Ad-DOPE and
Atetra-CMG-DOPE when applied as a 1 µL spots (50 µmol/L) on paper. Columns show the time of
contact in seconds of the FSL with the surface before being washed with PBS. The last clearly positive
reaction (defined as even reactivity over the spot area) in each column is indicated by a yellow circle.
2.2.3. Ionic Concentration
The effect of ionic strength of the application buffer was studied by preparing 50 µmol/L
Atri-Ad-DOPE and Atetra-CMG-DOPE in a pH 7 phosphate-citrate buffer and then adjusted the
ionic strength. The original isotonic buffer (1ˆ) was adjusted by diluting 1:1 with water to produce
the 0.5ˆ buffer, and sodium chloride was added to produce 2ˆ, 3ˆ, 4ˆmore salt than in an isotonic
buffer. In addition, a fresh opened vial of water was immediately used to prepare a salt-free diluent
(0ˆ). These ionic strength adjusted FSL constructs were applied to MG paper and allowed to be in
contact with the surface for between 1 and 1800 s before being washed in PBS pH 7. Binding of the FSL
constructs to the surface was then determined by EIA (Figure 10).
Essentially Atri-Ad-DOPE was unaffected by the presence of salts over a large concentration
range, with binding to the surface occurring within a second. In the absence of salt Atetra-CMG-DOPE
was also able to bind in 1 s, but in the presence of low levels of salt this binding time increased to
15 s. Further increases in salt levels had no effect. These results possibly relate only to MG paper and
performance on other surfaces (and with different concentrations of FSL constructs and pH) could
potentially produce different results to those obtained on paper.
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Figure 10. Effect of application buffer ionic concentration on the surface binding characteristics of
Atri-Ad-DOPE and Atetra-CMG-DOPE when applied as a 1 µL spots (50 µmol/L) on paper. Columns
show the time of contact in seconds of the FSL with the surface before being washed away with PBS.
The last clearly positive reaction in each column is indicated by a yellow circle.
2.2.4. Effect of Surface and FSL Delivery Solutions
The influence of the surface type on binding was evaluated by applying a 1 µL spot of 50 µmol/L
Atri-Ad-DOPE and Atetra-CMG-DOPE in a pH 7 buffer to three different surfaces (Figure 11). On
paper (cellulose ester) and stainless steel the Atri-Ad-DOPE construct produced good positive results
at 6 s, however on polyester film a strong positive result was obtained in 1 second. In contrast,
Atetra-CMG-DOPE took five min (300 s) to give a clear reaction on paper, and 15 min (900 s) on
stainless steel, but only 1 s on polyester film. These results clearly indicate the nature of the surface
will have significant impact on the rate at which the FSL is able to bind to the surface.
By adding 0.2% (v/v) of the surfactant Tween 20 (Tw20) to the PBS application buffer, the ability
of Atri-Ad-DOPE to bind to paper was negatively impacted with the binding time changing from
6 seconds to 900 s (15 min). In stark contrast, the addition of Tween 20 to the Atetra-CMG-DOPE
positively affected binding and reduced the binding time from 300 to 6 s. The effect of the reduction of
surface tension by the surfactant could also be seen with a larger diameter of the spot applied. These
results indicate the presence of a surfactant may have significant impact on the rate at which the FSL is
able to bind to the surface depending on the type of spacer (and potentially also the surface).
When both constructs were applied in 70% ethanol they were able to form a coating in 1 s on
all surfaces. These results suggest that application of the constructs in a solvent is preferable to their
interaction and binding with surfaces, presumably because the micelles are less stable.
It should be noted that CMG spacer FSL constructs are not soluble in 96% ethanol (Table 2).
Atri-Ad-DOPE is soluble in both 100% methanol and 96% ethanol and both Atetra-CMG-DOPE
and Atri-Ad-DOPE constructs were soluble in 100% isopropanol. The observation that tri and
tetrasaccharide CMG constructs were equally insoluble in 96% ethanol indicates the spacer was
responsible for this effect.
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Figure 11. Effect of FSL application buffer (PBS, surfactant (Tw20), 70% ethanol) on the binding
characteristics of Atri-Ad-DOPE and Atetra-CMG-DOPE when applied as a 1 µL spots (50 µmol/L) on
paper, stainless steel and polyester film. Columns show the time of contact in seconds of the FSL with
the surface before being washed away with PBS. The last clearly positive reaction in each column is
indicated by a yellow circle.
Table 2. Solubility of 1 mM Atri-Ad-DOPE, Atri-CMG-DOPE and Atetra-CMG-DOPE in methanol
and ethanol.
Solvent
Atri-Ad-DOPE Atri-CMG-DOPE Atetra-CMG-DOPE
Methanol Ethanol Methanol Ethanol Methanol Ethanol
96% + 1 + + P 2 + P
80% + + + + + +
70% + + + + + +
1 + = soluble, 2 P = precipitate (insoluble).
2.3. Stability
2.3.1. Serum
The need for the glycan coating to be stable in the presence of serum is critical to its applicability to
diagnostics assays. To evaluate serum stability we spotted Atri-Ad-DOPE and Atetra-CMG-DOPE onto
paper then soaked the spotted membranes in undiluted serum for 24 h. In addition undiluted serum
and 1:5 diluted (in PBS) serum was tested against the FSL spots for up to 4 h. Following incubation,
plates were washed and tested by EIA with monoclonal anti-A (Figure 12). Group AB serum was
selected so as not to contain anti-A, which would interfere with the binding of the monoclonal
anti-A (whose purpose was to detect the presence of blood group A FSL constructs). After 24 h of
contact with serum the Atri-Ad-DOPE constructs were still present although the Atetra-CMG-DOPE
constructs had been mostly removed. Between 0.5 to 4 h contact with serum both Atri-Ad-DOPE and
Atetra-CMG-DOPE were clearly present. No differences were noted with diluted serum where lipid
loading was reduced to 20% of normal (not tested at 24 h). These results show that both constructs
are sufficiently stable on paper membranes to undertake diagnostic assays with up to 4 h incubation
against undiluted serum.
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Figure 12. Effect of contact with human serum on the binding characteristics of Atri-Ad-DOPE and
Atetra-CMG-DOPE when applied as a 1 µL spots (50 µmol/L) on paper, and exposed to serum for up
to 24 h. After exposure to serum the presence of blood group A FSL constructs was determined by EIA
with monoclonal anti-A. Serum concentration values relate to 100% being undiluted serum and 20% is
serum diluted 1:5.
2.3.2. Alcohol
To partially evaluate the strength and mechanisms of binding, printed FSL constructs were
exposed to varying concentrations of alcohol. In addition to the two primary constructs Atri-Ad-DOPE
and Atetra-CMG-DOPE (Figure 1) two additional constructs Atetra-Ad-DOPE and Atri-Chol (Figure 13)
were also available for this analysis.
All four FSL constructs were printed onto paper, dried and then soaked in either water, 50%, 70%
or 100% methanol (MeOH) or 50%, 70% or 96% ethanol (EtOH) for 1 h. After exposure, the treated
surfaces were dried and assembled into a microplate for EIA immunostaining. Exposure of these
printed constructs to water for an hour had no consequence, with all constructs staining strongly by
EIA. In contrast, exposure to 50% ethanol or methanol removed almost all variations of blood group A
FSL from the paper. Increasing the alcohol concentration to 70% resulted in less efficient removal of
Atri-Ad-DOPE (3A0ad) and Atetra-CMG-DOPE (4A2cd), and this was even less effective at >96%. At
all concentrations of alcohol the Atri-Chol (3A0as) construct was removed, indicating at least some
direct involvement of the lipid tail in the adhesion process. Furthermore the size of the carbohydrate
has a role (albeit minimal), as seen in the results observed with 70% EtOH and 100% MeOH, where the
more hydrophilic A tetra construct (4A2ad) appeared slightly more easily removed from the surface
than was the trisaccharide (3A0ad). The type of the FSL spacer when exposed to 70% EtOH and 100%
MeOH had a substantial effect with the tetrasaccharide with the adipate based spacer (4A2ad) being
Int. J. Mol. Sci. 2016, 17, 118 13 of 18
more easily removed than the tetrasaccharide with the CMG spacer (4A2cd). Of particular note was
the differences observed with 100% methanol and 96% ethanol, with ethanol much less effective at
removing the adipate based FSLs (3A0ad and 4A2ad) than was methanol. This effect was more striking
with the tetrasaccharide being more resistant to removal in 96% ethanol than in methanol. These
results are supported by the observations that the Atetra-CMG-DOPE and Atri-CMG-DOPE disperse
in 100% methanol but are insoluble in 96% ethanol (Table 2).
Figure 13. Schematic diagrams of two additional blood group A function-spacer-lipid (FSL) constructs
used in this paper. The upper schematic Atetra-Ad-DOPE shows an FSL with a tetrasaccharide blood
group type 2 A antigen with an adipate spacer while the lower schematic is of an A trisaccharide with
a cholesterol lipid tail (Atri-Chol).
It should be noted that some of these surface effects reported here for paper are surface type
dependent and different interactions and stability are observed on different surfaces (e.g., Figure 14).
Figure 14. Elution profiles of four blood group A FSL variants printed on paper and exposed to 50%,
70% and 96% ethanol and methanol for 1 h. The FSL variants Atri-Ad-DOPE (3A0ad), Atri-Ad-sterol
(3A0as), Atetra-Ad-DOPE (4A2ad) and Atetra-CMG-DOPE (4A2cd) when exposed to water (H2O) for
1 h all stained strongly by EIA. Exposure to 50% alcohol was effective at removing most constructs,
but increasing concentrations of alcohol were less effective. Differences observed can be partially
attributable to the type of lipid tail, spacer and size of the saccharide moiety. These results are probably
only valid for this type of surface (paper).
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2.3.3. Detergent/Surfactant
To further evaluate the strength and mechanisms of binding, printed FSL constructs were
exposed to high concentrations of two different routine laboratory detergent/surfactants: Tween
20 (Polyethylene glycol sorbitan monolaurate—a non-ionic detergent) and Triton X-100 (Polyethylene
glycol tert-octylphenyl ether—a non-ionic surfactant). Two different FSL variants were available for
evaluation: Atri-Ad-DOPE and Atetra-CMG-DOPE. Both FSL constructs were printed onto paper or
nylon PA66 nanofibres then soaked in either water, 70% methanol or 5% Tween 20 or 5% Triton X-100
for 1 h, then washed and stained by EIA (Figure 15). The 70% methanol results on paper correlated
with previous results of significant elution from the paper surface, however 70% methanol removal
of FSLs was much less effective on the nylon nanofibres. The 5% Tween 20 solution was able to
remove most of the Atetra-CMG-DOPE constructs from paper but was less effective at removing
the Atri-Ad-DOPE constructs. Concentrations of Tween 20 less than 1% did not have any effect on
removal of Atri-Ad-DOPE from paper (results not shown). In contrast, soaking the FSL printed nylon
membrane in 5% Tween 20 appeared to either have no effect, or possibly slight enhancement of the
immunoreactivity of the FSL constructs present.
The surfactant Triton X-100 in contrast was able to effectively remove both constructs from paper
(even with concentrations as low as 0.05%—not shown) however it was much less effective in removal
of FSL constructs from nylon nanofibres. The adipate spacer FSL, Atri-Ad-DOPE (Figure 15—FSL-Atri)
was also more resistant to removal than the CMG spacer construct on nylon nanofibres. Blood group
A FSL was removed from polyester film with all concentrations of alcohol and both detergents.
Together these results clearly indicate variability of the stability of different FSL coatings
on different surfaces and the need to experimentally determine and optimise each construct for
each surface.
Figure 15. Detergent/surfactant stability of blood group A FSL on paper and nylon nanofibres. FSL
variants Atri-Ad-DOPE (printed as FSL-Atri in image) and Atetra-CMG-DOPE (printed as FSL-Atetra
in image) were printed on both paper and nylon nanofibres, exposed to deionised water (H2O), 70%
methanol (MeOH), 5% Tween 20 or 5% Triton X-100 for 1 h, washed then immunostained by EIA.
3. Experimental Section
3.1. Synthesis of FSL Constructs
The FSL glycans described in the paper, and other related FSL glycans, and their synthesis are
described in detail elsewhere [4,5,8].
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3.2. Surfaces
3.2.1. Disc Coupons
Disc coupons for CDC and RDR reactors (Figure 2) were used as defined surface materials and
were obtained from BioSurface Technologies Corporation (Bozeman, MT, USA). Coupons were labelled
by placing a 1 µL drop of FSL (50 µmol/L in water) at either the 12 o’clock position (Atri-Ad-DOPE) or
6 o’clock position (Atetra-CMG-DOPE) and allowed to air dry. Coupons were washed 3ˆwith PBS
before visualisation of the FSL by EIA.
3.2.2. Membranes and Planar Surfaces
A variety of filtration membranes and planar surfaces including metals and papers (Figure 4)
were obtained from different sources. Filtration membranes were obtained from Sterlitech, USA
and Millipore, France; TLC plates (Alugram SIL G/UV silica gel 60, and C18 RP-18W) from
Macherey-Nagel, Düren, Germany; microspheres from Nanomi B.V., Oldenzaal, The Netherlands and
Millipore, Pithiver, France; gold and silver foils from The Gold Leaf Factory International, Seaford,
Vic, Australia; silver dressing from Silverlon, Argentum Medical, Geneva, IL, USA; and 24 varieties of
coated and uncoated papers from Spicers Paper, Auckland, New Zealand. Membranes and planar
surfaces were labelled with inkjet printer delivered FSL constructs and/or by direct application
(dipping, spotting or paintbrush). Nanofibres for printing were supplied by Revolution Fibres,
Auckland, New Zealand.
3.2.3. Electrospinning Nanofibres Incorporating FSL Constructs
Nanofibres incorporating FSL constructs were prepared using an in house apparatus at the
premises of Revolution Fibres Ltd., Auckland, New Zealand [11]. Dispersions of polyvinyl butyral
(PVB) were prepared at a concentration of 10% (w/v) in 100% ethanol. Dispersions of cellulose acetate
(CA) were prepared at a concentration of 17% (w/v) in 70:15:15 (v/v/v) MEK/DMA/DMF. Mats of
nanofibres were electrospun from these dispersions with or without the addition of Atri-Ad-DOPE.
Where blood group A FSL constructs were added to the dispersions 50 µL of a 10 mg/mL solution of
the construct in 100% ethanol was added to a 5 mL volume of the dispersion of the polymer to provide
a final concentration of 100 µg/mL. The speed of rotation, the distance to the collector plate and voltage
were adjusted to optimise deposition of the nanofibres electrospun from each of the dispersions. Spun
fibres twisted into threads were immobilized at one end with 80 micron document laminating film
then immunostained by the EIA technique.
3.3. Methods for FSL Coating Surfaces
3.3.1. Direct Application
The easiest and fastest approach to applying an FSL to a surface is by simple contact. A variety
of direct application methods were available including applying the construct as a 1 µL spot to a
surface with a multi-pipette, or application with a paintbrush, or dipping into a solution or flooding
the surface. Each variation including surface type, FSL concentration, buffer, drying rate, etc., has
the potential to create a slightly different coating by affecting the way the constructs assembles at the
surface [4]. Unless stated otherwise the usual concentration for direct application of FSL constructs
was at a concentration 50 µmol/L.
3.3.2. Inkjet Printing
FSL constructs for printing were prepared as 600 µmol/L solutions in PBS containing 0.25%
bromophenol blue (a visualisation dye which is lost during incubation) [8]. An alphanumeric code
representing each FSL construct or the name of surface the FSL was being modified (Figures 3–5, 12, 14
and 15) was printed with an Epsom stylus T21 inkjet printer where the inkjet cartridge was loaded
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with the appropriate FSL construct. Printer heads and cartridges were thoroughly cleaned with 70%
methanol followed by PBS and blank printing between experiments.
3.4. Microplate Assembly
Where appropriate to allow multiple reactions microplates were prepared either with surfaces
pre-printed with FSL constructs (Figure 3) or unmodified for later spot application of FSL constructs
(Figures 8–11). Fibrous surfaces such as paper were first prepared by using a laser cutter (X660
Universal laser Systems, Scottsdale, AZ, USA) to cut reaction well shapes from one side of an 80 micron
document laminating film (to exclude laminating over the printed FSLs) which was then laminated
(Document Laminator, GBC 1200, Lake Zurich, IL, USA) onto the either FSL printed surface or a
blank surface, leaving the reaction areas exposed. This step, which both stabilizes the membrane
and prevents leakage between microwells was not required for non-fibrous surfaces such as stainless
steel or polyester film. A 2 mm acrylic (Clear Cast Acrylic, Modern Plastics, Auckland, New Zealand)
template covered with one-piece of double-side adhesive sheet was then laser cut to shape and adhered
to the surface, to create reaction wells (Figure 3). Prepared plates were stored at room temperature
until ready for use.
3.5. Visualisation of Blood Group A FSL Constructs
3.5.1. Enzyme Immunoassay (EIA)
FSL coated surfaces were first blocked with BSA-PBS (2% bovine serum albumin in phosphate
buffered saline, pH 7.2) for 30 min then decanted. Each surface or prepared microplate well was
flooded or filled with IgM monoclonal anti-A (Epiclone anti-A, Cat# 0261, CSL, Seaford, VIC, Australia)
diluted 1:4 with BSA-PBS and then incubated for 30 min at RT. This anti-A reagent has been previously
established to show specific binding against the blood group A antigen, including in the form of FSL
constructs [4,5,7,8,10,11]. Unprinted areas within the assay are internal blanks.
Microplates and surfaces were washed 6 times by immersion for 20 s in beakers of fresh PBS. Each
microwell or surface was filled or flooded with goat anti-mouse total immunoglobulin conjugated to
alkaline phosphatase (Millipore, Temecula, CA, USA) diluted 1:1000 in 2% BSA-PBS and incubated
for 30 min at room temperature before being washed 6 times in PBS. Precipitating chromogenic
substrate (NBT/BCIP stock solution, 18.8 mg/mL nitro blue tetrazolium chloride and 9.4 mg/mL
5-bromo-4-chloro-3-indolyl phosphate toluidine salt in 67% DMSO (v/v); Roche, Mannheim, Germany)
was diluted 1:50 in substrate buffer (100 mM Tris, 100 mM NaCl, 50 mM MgCl2, pH 9.5) and added to
each microwell or flooded onto surfaces. Development of reactions at RT occurred within 4 minutes
and the reaction was stopped by rinsing with water. Developed reactions were allowed to air dry and
could be stored unprotected at RT. Caution: the ability of the NBT/BCIP precipitate to be retained on
the surface can significantly influence the interpretation of the result.
3.5.2. Cell Binding via Antibody Bound to FSL
An alternative method to visualisation by EIA was to allow the binding of cells to the surfaces
via IgM antibody. FSL modified membranes were blocked by flooding with BSA-PBS (2% bovine
serum albumin in phosphate buffered saline, pH 7.2) for 60 min then decanted. Surfaces were then
flooded with IgM monoclonal anti-A (Epiclone anti-A, Cat# 0261, Seaford, CSL, Australia) diluted
1:10 with BSA-PBS for 1 h. Surfaces were then washed 6 times by immersion for 20 s in beakers of
fresh PBS. Each washed membrane was then flooded with a 2% suspension of washed blood group
A red cells and allowed to incubate for 1 h (incubation allows the red cells to settle onto the surface).
Membranes were very gently washed by flooding the surface with PBS (from a pipette away from the
surface) until the unbound cells were cleared. The adhesion of the cells is very fragile on most surfaces
(except cotton) and gentle washing is essential.
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An alternative method is to apply the constructs onto microspheres, and then attach antibody to the
microspheres. Provided antibody is added in excess the beads will be unable to cross-link. When washed
these blood group A FSL anti-A coated microspheres can then be used to capture blood group A cells.
3.6. Scanning Electron Microscopy (SEM)
An Hitachi SU-70 Analytical Field Emission scanning electron microscope (SEM) (Tokyo, Japan)
was used to capture surface images after being sputter coated with platinum for 60 s (15 keV
accelerating voltage). SEM analysis of surfaces with cells were first treated by flooding with 0.5%
glutaraldehyde in PBS for 20 min and then gently washed with water.
4. Conclusions
Experimental data is clearly able to show the potential of FSL constructs when optimised to
rapidly (within 1 s) coat almost any non-biological surface. However this labelling and its stability
are clearly variable dependent. In order to achieve optimal and rapid labelling, the type of constructs
used (spacer, lipid and functional head size), the method of application onto a surface (concentration,
diluent, pH, ionic strength, surfactant, solvent, etc.) should all be determined and optimised for each
surface intended to be modified. It is of note that most variability was only observed with contact
times less than 5 min, and if a 30 min FSL contact time was used, then most of these variable dependent
interactions would not be observed. Currently dynamic light scattering, atomic force microscopy, and
other physical methods are in progress to allow us to determine detailed FSL surface layer architectures;
which will assist in determining optimal coating conditions.
Physical adsorption of FSL constructs to surfaces although not a permanent modification are
sufficiently robust to be suitable for enzyme immunoassays, ligand-receptor and cellular/biological
interactions. Together with the ability to be able to use the same or different constructs to modify
cells and viruses [4,5] and simultaneously use multiple FSL constructs, including non-glycan FSL
variations [7], FSL modification of surfaces is a useful alternative and additive technology to existing
covalent glycosylation methods.
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